crizotinib | |
---|---|
Trade Name | Xalkori |
Orphan Indication | Non-small cell lung cancer |
USA Market Approval | USA |
USA Designation Date | 2010-09-13 00:00:00 |
Sponsor | Pfizer, Inc.;10646 Science Center Drive;San Diego, California, 92121 |
Related Access Program